These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2650329)

  • 1. Immunological reactivity before and after cardiac transplantation.
    Kaslík J; Kocandrle V; Fabián J; Macurová H; Korcáková L
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2547. PubMed ID: 2650329
    [No Abstract]   [Full Text] [Related]  

  • 2. [Measures for critical support at the pre- and post-transplantation stage].
    Ruza F; Alvarado F; García S
    An Esp Pediatr; 1989 Sep; 31 Suppl 39():60-4. PubMed ID: 2490333
    [No Abstract]   [Full Text] [Related]  

  • 3. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of interleukin-2 receptor positive circulating lymphocytes and acute cardiac rejection.
    Fieguth HG; Haverich A; Hadam M; Kemnitz J; Dammenhayn L
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2517-8. PubMed ID: 2650318
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytoimmunologic monitoring for the noninvasive diagnosis of cardiac rejection.
    Fieguth HG; Haverich A; Schaefers HJ; Wahlers T; Kemnitz J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2541-2. PubMed ID: 3274557
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytoimmunologic monitoring for the diagnosis of acute rejection after heart transplantation.
    Wijngaard PL; van der Meulen A; Schuurman HJ; Gmelig Meyling FH; Heyn A; Borleffs JC; Jambroes G
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2521-2. PubMed ID: 2650320
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimization of immunosuppressive treatment after heart transplantation.
    Gallucci V; Livi U; Faggian G; Mazzucco A; Stellin G; Chiominto B; Bortolotti U
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2490-1. PubMed ID: 2495639
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of immunosuppressive agents for prevention of graft rejection in allogeneic bone marrow transplantation.
    Uharek L; Gassmann W; Fleischhauer D; Wottge HU; Loeffler H; Müller-Ruchholtz W
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3042-4. PubMed ID: 2650420
    [No Abstract]   [Full Text] [Related]  

  • 9. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression in cardiac transplantation.
    Rose EA; Addonizio LJ
    Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
    [No Abstract]   [Full Text] [Related]  

  • 11. Relevance of immunological parameters to detect allograft rejection in heart transplant recipients.
    Renna Molajoni E; Bachetoni A; Cinti P; Sallusto F; Alfani D; Macchiarelli A; Scibilia G; Cassisi A; Marino B; Cortesini R
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2534-6. PubMed ID: 2650326
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytoimmunological monitoring to detect rejection after heart transplantation.
    Jutte NH; Daane R; van den Bemd JM; Hop WC; Essed CE; Simoons ML; Bos E; Weimar W
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2519-20. PubMed ID: 2650319
    [No Abstract]   [Full Text] [Related]  

  • 13. Rejection of the transplanted heart.
    Murdock DK; Collins EG; Lawless CE; Molnar Z; Scanlon PJ; Pifarre R
    Heart Lung; 1987 May; 16(3):237-45. PubMed ID: 3553082
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medical management before and after homologous transplantation of the kidney].
    Xu QJ
    Zhonghua Yi Xue Za Zhi; 1982 Oct; 62(10):591-4. PubMed ID: 6817883
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytoimmunologic monitoring and heart transplantation.
    Hanson CA; Bolling SF; Stoolman LM; Schlegelmilch JA; Abrams GD; Miska PT; Deeb GM
    J Heart Transplant; 1988; 7(6):424-9. PubMed ID: 3062148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Organ transplantation: epidemiological and immunological aspects; principles of treatment and surveillance; complications and prognosis; ethical and legal aspects].
    Lebranchu Y; Sirinelli A; Wolf P; Mornex JF
    Rev Prat; 2004 Dec; 54(20):2295-304; quiz 2304. PubMed ID: 15736544
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of HLA molecules on peripheral blood lymphocytes: a useful monitoring parameter in cardiac transplantation.
    Blanco-Garcia RM; López-Alvarez MR; Pascual-Figal DA; Polo-Garcia L; Guerra N; Campillo JA; Muro M; Garcia-Alonso AM; Marin-Moreno I; Valdes M; Alvarez-López MR; Minguela A
    Transplant Proc; 2007 Sep; 39(7):2362-4. PubMed ID: 17889190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of cardiac transplants with beta 2-microglobulin, cytoimmunological monitoring and endmyocardial biopsy: what's their value in detecting rejection?
    Semik M; Konertz W; Westphal E; Heusermann U; Friedl A; Bernhard A
    Bibl Cardiol; 1988; (43):133-6. PubMed ID: 3067712
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heart transplantation in 1984].
    Cabrol C
    Ann Chir; 1985 Mar; 39(2):67-71. PubMed ID: 3890675
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and treatment of cardiac allograft rejection.
    O'Connell JB; Renlund DG
    Cardiovasc Clin; 1990; 20(2):147-62. PubMed ID: 2404596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.